Page last updated: 2024-11-03

risperidone and Epistaxis

risperidone has been researched along with Epistaxis in 5 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Epistaxis: Bleeding from the nose.

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Binici, NC1
Güney, SA1
Coskun, M1
Mukaddes, NM1
Mowla, A1
Dastgheib, SA1
Ebrahimi, AA1
Pani, A1
Harrison-Woolrych, M1
Clark, DW1
Srinivas, VR1

Other Studies

5 other studies available for risperidone and Epistaxis

ArticleYear
Epistaxis as an Unexpected Side Effect of Aripiprazole and Risperidone Treatment in Two Children with Two Different Psychiatric Diagnosis.
    Journal of child and adolescent psychopharmacology, 2017, Volume: 27, Issue:8

    Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum D

2017
Possible risperidone-related gastrointestinal bleeding or epistaxis in two pediatric cases.
    Journal of child and adolescent psychopharmacology, 2008, Volume: 18, Issue:3

    Topics: Child; Epistaxis; Gastrointestinal Hemorrhage; Humans; Male; Risperidone

2008
Nasal bleeding associated with fluoxetine and risperidone interaction: a case report.
    Pharmacopsychiatry, 2009, Volume: 42, Issue:5

    Topics: Depression; Drug Interactions; Epistaxis; Fluoxetine; Follow-Up Studies; Humans; Male; Risperidone;

2009
Nose bleeds associated with use of risperidone.
    BMJ (Clinical research ed.), 2004, Jun-12, Volume: 328, Issue:7453

    Topics: Adult; Epistaxis; Female; Humans; Male; Middle Aged; Risperidone; Serotonin Antagonists

2004
Postmarketing surveillance is needed.
    BMJ (Clinical research ed.), 2004, Jul-03, Volume: 329, Issue:7456

    Topics: Adverse Drug Reaction Reporting Systems; Epistaxis; Humans; Risperidone; Serotonin Antagonists

2004